Serious Games Rehabilitation Programme to Treat Gant and Balance Disorders in Patients With Parkinson's Disease

Institut National de la Santé Et de la Recherche Médicale, France1 site in 1 country25 target enrollmentJuly 18, 2018

ConditionsParkinson Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Parkinson Disease
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Enrollment: 25
Locations: 1
Primary Endpoint: Duration of the time-up-go test
Status: Completed
Last Updated: 4 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To test the effects of a serious game rehabilitation programme in 50 patients with Parkinson's disease with gait and balance disorders in a randomised controlled study

Registry

clinicaltrials.gov

Start Date

July 18, 2018

End Date

December 6, 2021

Last Updated

4 months ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Parkinson's disease
•Gait and balance disorders resistant to dopaminergic medication

Exclusion Criteria

•contra-indication to magnetic resonance imaging

Outcomes

Primary Outcomes

Duration of the time-up-go test

Time Frame: change between baseline and at 6 weeks

Secondary Outcomes

Step length(change between baseline and at 6 weeks)
freezing of gait questionnaire(change between baseline and at 6 weeks)
Montreal Cognitive Assessment(change between baseline and at 6 weeks)
step velocity(change between baseline and at 6 weeks)
gait and balance scale(change between baseline and at 6 weeks)
Magnetic resonance imaging(change between baseline and at 6 weeks)
Duration of the time-up-go test(change between baseline and at 18 weeks)
Movement disorders Unified Parkinson's disease rating scale(change between baseline and at 6 weeks)
Parkinson's disease quality of life scale(change between baseline and at 6 weeks)